Archive
2020, Volume 6
2019, Volume 5
2018, Volume 4
2017, Volume 3
2016, Volume 2
2015, Volume 1




Volume 6, Issue 1, June 2020, Page: 1-5
Epidemiological, Clinical and Therapeutic Aspects of Laryngeal Papillomatosis in Mali
Fatogoma Issa Kone, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Kadidiatou Singare, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Kadiatou Traore, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Oumou Coulibaly, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Naouma Cisse, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Siaka Soumaoro, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Djibril Samake, Reference Health Center V., Bamako, Mali
Neuilly Tafo, Reference Health Center II., Bamako, Mali
Diarra Kassim, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Konate N’faly, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Boubacary Guindo, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Timbo Samba Karim, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Keita Mohamed Amadou, Department of Surgery, University Hospital Gabriel Toure, Bamako, Mali
Received: Oct. 22, 2019;       Accepted: Dec. 5, 2019;       Published: Jan. 31, 2020
DOI: 10.11648/j.ijo.20200601.11      View  408      Downloads  79
Abstract
Objectives: To study the epidemiological and clinical aspects and to identify our therapeutic difficulties. Material and Methods: this is a quantitative retrospective study covering a 9-year period from January 2009 to March 2017. Patient on patients seen outpatient dyspnea and dysphonia or referred to the University Hospital of Gabriel Touré in Bamako. Results: The hospital prevalence was 0.05%. The age group of 7 to 12 years represents 37.5% of cases. The average age of patients has increased from 11.71 years to 1 year to 36 years. The sex ratio was 1.5. The disease spent 28 months at 28.1%. The main signs found were dysphonia, dyspnea and touch, which were 90.6%, 6.3% and 3.1% respectively. Laryngoscopy in suspension detected 68.8% of lesions in the glottic cleft. The subglottic stage in 4 cases, Susglottic in 6 cases. Peeling with the forceps has been performed in all our patients. Conclusion: laryngeal papillomatosis remains a problem in our context. Dysphonia and dyspnea are the main signs of discovery of this condition. Diagnostic delay due to ignorance by some practitioners and geographical distance. This delay in diagnosis is responsible for the aggravation of the symptoms that may justify the indication of a certain tracheotomy. Peeling with a forceps during direct laryngoscopy is the only therapeutic alternative in our context.
Keywords
Papillomatosis, Larynx, Peeling, Endoscopy
To cite this article
Fatogoma Issa Kone, Kadidiatou Singare, Kadiatou Traore, Oumou Coulibaly, Naouma Cisse, Siaka Soumaoro, Djibril Samake, Neuilly Tafo, Diarra Kassim, Konate N’faly, Boubacary Guindo, Timbo Samba Karim, Keita Mohamed Amadou, Epidemiological, Clinical and Therapeutic Aspects of Laryngeal Papillomatosis in Mali, International Journal of Otorhinolaryngology. Vol. 6, No. 1, 2020, pp. 1-5. doi: 10.11648/j.ijo.20200601.11
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Mohamed A AG, Timbo S K, Konipo-Togola F. La papillomatose laryngée: Réflexions à propos de 06 cas récents dans le service d’ORL-CCF de l’hôpital Gabriel touré Bamako (mali). Médecine d’Afrique Noire. 1996, 43: 12.
[2]
Awad R, Shamil E, Aymat-Torrente A, Gibbins N, Harris S. Management of laryngeal papillomatosis using coblation: another option of surgical intervention. European Archives of Oto-Rhino-Laryngology. 2019. doi.org/10.1007/s00405-019-05354-3.
[3]
Fuchsmanec, Ayari – Khalfallalh S, Coulombeau B, Froechlich P. Papillomatose laryngée. Encycl Med Chir. Oto-rhino-laryngologie 2012, 20: 705-a-10.
[4]
Saumet L, Damay A, Jerziorski E, Cartier C, Rouleau C, Margueritte G, et al. Papillomatose laryngée sévère évoluant vers un carcinome broncho-pulmonaire associé à HPV 11chez un enfant de 15ans: à propos d’un cas. Arch pediatr. 2011; 18: 754-7.
[5]
Derkay CS, Wiatrak B. La papillomatoses laryngée de l’enfant. Recurrent respiratory papillomatosis a review. Laryngoscope. 2008; 118: 1236- 47. 241.
[6]
Cook Jr, Hill Da, Humphrey Pa, Pfeifer Jd, El-MoftySk, squamous cell carcinoma arising in recurrent respiratory papilloatosis with pulmonary involvement: emmerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol. 2000; 13 (8): 914-8.
[7]
K Pémissi E, Agbere Ab, Sossou K. papillomatose laryngée de l’enfant. Rev laryngol. 1995; 116: 335-338.
[8]
CristenPh, Jorgen K, Grontred A. juvenile papillomatosis of the larynx, the country of funen, a 45 year follow-up from danemarkotolaryngol. 1984; 412: 3739.
[9]
Timbo S. K, Konipo-Togola F, Mohamed Ag, Keita M A, Sacko H B, TraoreL. papillomatoselaryngée au mali. Bull soc patho exot. 2002; 95: 31-33.
[10]
Diouf R, Ouaba, N’diaye I, Diop Em, Diop Ls, la papillomatose laryngée: à propos de 27 cas dakar med. 1989; 34: 102-106.
[11]
Bauman Nm, Smith R J. recurrent respiratory papillomatosis pediatric clinic north am. 1996; 43: 1385-1401.
[12]
N’diaye M, N’ DiayeIc, I Tière, O Fa, Tall, Diallo Big, Diouf R, DioufEhm. Papillomatose laryngée de l’enfant. f r orl. 2008; 94: 379-382.
[13]
Zour A., Raji A: papillomatose laryngée: aspects diagnostics thérapeutique et évolutifs [thèse]. Service d’orl et de chirurgie cervico-faciale CHU Mohamed Marrakech a propos de 20 cas faculté de médecine et de pharmacie Marrakech; 2011.
[14]
O Maliki, H. Nouri, T. Ziad, Y. Rachid, L. Averdour, A. Raji. Papillomatose laryngée de l’enfant: aspect épidémiologique, thérapeutiques et évolutifs à propos de 21 cas journal de pédiatrie et de puériculture. 2012; 25: 237-241.
[15]
Ondzotto G, Galiba J, Kouasi B, Ehoua F. La papillomatose laryngée: diagnostic précoce, à propos de 7 cas diagnostiques au chu de brazaville, congo. med tropicale. 2002; 62: 163-165.
[16]
Silverberg Mj, Thorsen P, Lindeberg H et al condylome in pregnancy is strogly predictive of juvenile –onset recurrent respiratory papillomatosisobstetgynecol. 2003; 101: 645-652.
[17]
Weys D Ou, Kashima Mk. tracheal involvement in laryngeal papillomatosis laryngoscope. 1983; 93: 45-48.
[18]
Mesolella M, Motta G, Larguardia M, Galliv. papillomatosis of the larynx: treatement with CO2 laser. B E N T. 2006; 2: 51-54.
[19]
Patel N, Rowe M, Turkel D. Treatement of recurrent respiratory papillomatosis in the children. annotalrhinol laryngol. 2003; 11: 9-10.
[20]
Pasquate K, Wiatrak B, Wooley A, Lewis L. microdebrideur versus CO2 laser removal of recurrent respiratory papillomatosis: a propective analysis laryngoscope; 2003; 113: 139-143.
[21]
LoventholBg, Kashima Hk, Mounthp, Thurmond, Chapman S, Buckkleys et al. Long term reponsepapillomatose of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon. N Engl J Med. 1991; 325; 613-637.
[22]
El Aatmani M, Steinnaetz A, Debry C, Leveque D, Koffel Jc, Beretz. a propos d’un cas de traitement de papillomatose laryngée récidivante par injection intra lésionnelle de cidofovir. J pharma clin. 2002; 21: 287-290.
[23]
Traissac L, Devars F, Petit J, Portman D, Paraxanthros M, Benchaqroun L et al. Résultat du traitement de la papillomatose juvénile du larynx à propos de 158 cas. rev laryngeal. 1987. 108: 221-224.
[24]
Toussaint B, Mayot D, Perrain C. transformation maligne de la papillomatose laryngée de type juvénile. Ann Otolaryngeal Chir Cervico Fac. 1993; 110: 285-290.
Browse journals by subject